Given that cognitive impairment in AD is thought to be driven by synaptic dysfunction and that ageing is the most important risk factor for AD, these findings overall suggest that age- and disease-associated changes in RBP expression could significantly contribute to the pathophysiology of AD. The gene discussed is RENBP; the disease is Cognitive impairment.